pfizer's philosophy for orphan drugs - extended cut
Published 9 years ago • 177 plays • Length 1:42Download video MP4
Download video MP3
Similar videos
-
1:12
pfizer's rare disease unit - advancing the discovery, development, and availability of orphan drugs
-
1:15
pfizer's rare disease programs
-
56:56
orphan drugs: making rare disease rarer
-
1:16
the role of big pharma in orphan drug development and commercialization
-
17:18
andrew callos of pfizer on building a rare disease franchise at world orphan drug congress usa 2013
-
1:06:37
senescent cells cause ageing - how and what can we do about it? | prof richard faragher
-
4:54
new drug slows vision loss, improves quality of life for people with age-related eye disease
-
25:54
alex zhavoronkov - from ai-powered drug discovery to longevity medicine
-
1:44
why aci developed a conference for orphan drugs and rare diseases
-
26:58
andrew callos of pfizer on sustainable business in rare disease at world orphan drug congress usa
-
2:51
how pfizer rare disease are differentiating themselves
-
12:20
rare disease collaboration model - big pharma embraces a new approach to drug development
-
1:06
some advice for developing orphan drugs
-
4:14
pfizer – together caring for rare disease
-
1:04
checkorphan: the longest running website focused exclusively on rare diseases
-
1:35
pfizer to sell drugs at not-for-profit price to world's poorest nations
-
1:05
pfizer’s commitment to rare diseases
-
2:00
rare disease drugs and market implications
-
1:39
the orphan drug act - how much has changed since 1983?
-
2:27
may orfali of pfizer on challenges and opportunities ahead for the orphan drug community
-
4:26
fabrizia bignami (eurordis), speaks about 10 years of orphan drug regulation in europe.